Even as a day-long nationwide dry run to check the best way to vaccinate people against Covid-19 started in the country on Friday, an SBI research report says the phase 1 vaccination covering 30 crore people will cost Rs 21,000 to Rs 27,000 crore. The second phase, involving another 50 crore, will need additional Rs 35,000-45,000 crore, it says. This is around 0.3-0.4 per cent of GDP.
In another study conducted by YouGov in association with News18, it is claimed that people have been waiting for the vaccine ever since the pandemic pushed them indoors. Majority of people in the survey conducted among 1015 urban Indian respondents said they are likely to take that shot in the arm as soon as the vaccine is available.
According to the survey, 68% of urban Indians are keen on taking the vaccine once it becomes available for all. Only 8% have shown reluctance in taking the vaccine, while 24% said they are unsure.
The State Bank Of India research report says that the government aims to vaccinate 30 crore people on priority basis by August 2021 and 50 crore private individuals by 2022-end.
The priority group is made up of health care workers, policemen, soldiers and volunteers, and vulnerable people — mostly citizens above the age of 50 and 10 million others with serious comorbidities.
SBI estimates the administration cost as Rs 100-150 per dose and cost per dose of Rs 250-300 per person to the government by Serum Institute of India, whose vaccine ‘Covishield’ has been approved for emergency use. This means the per person cost would be around Rs 700-900.
Bharat Biotech, which has also received approval from the drug regulators, has said the cost of its vaccine would be lower than Rs 100 per dose, though it is yet to come up with a definitive price of its vaccine.
The SBI think tank says India will require around Rs 56,000-72,000 to administer vaccines to 80 crore people.